Can light boost PRP's power against hair loss?

NCT ID NCT07739147

Not yet recruiting Disease control Sponsor: Kimberly Meathrel Source: ClinicalTrials.gov ↗

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This trial compares three types of platelet-rich plasma (PRP) injections for androgenetic alopecia, the most common form of hair loss. Participants receive either standard PRP, PRP enhanced with red light, or PRP enhanced with blue light, and are blinded to which type they get. The study measures changes in hair density and other hair metrics over 12 months using trichoscopy. The goal is to see if light-enhanced PRP improves hair growth outcomes compared to standard PRP.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Platelet-rich plasma (PRP) injections, with or without red or blue light enhancement
What this could lead to: If light-enhanced PRP proves more effective, it could offer a better non-surgical option for treating common hair loss.
What could go wrong: This is a very early, small trial, so results may not be conclusive or apply broadly. PRP effects vary, and light enhancement may not add benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANDROGENETIC ALOPECIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alopecia androgenetic alopecia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANDROGENETIC ALOPECIA

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.